CD8A and neoplasm: Most importantly, tumor cells undergoing EMT decrease the expression of MHC class I molecules, making them resistant to CD8+ T cell cytotoxicity, but more susceptible to NK cell lysis (Tallerico et al., 2013; Ferretti et al., 2020; Melaiu et al., 2020; Figure 1).